Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer.
Whang YE, Armstrong AJ, Rathmell WK, Godley PA, Kim WY, Pruthi RS, Wallen EM, Crane JM, Moore DT, Grigson G, Morris K, Watkins CP, George DJ. Whang YE, et al. Among authors: armstrong aj. Urol Oncol. 2013 Jan;31(1):82-6. doi: 10.1016/j.urolonc.2010.09.018. Epub 2011 Mar 10. Urol Oncol. 2013. PMID: 21396844 Clinical Trial.
Anti-angiogenic therapy in renal cell cancer.
Srinivasan R, Armstrong AJ, Dahut W, George DJ. Srinivasan R, et al. Among authors: armstrong aj. BJU Int. 2007 May;99(5 Pt B):1296-300. doi: 10.1111/j.1464-410X.2007.06834.x. BJU Int. 2007. PMID: 17441927 Review.
Cell signaling modifiers in prostate cancer.
Chen FL, Armstrong AJ, George DJ. Chen FL, et al. Among authors: armstrong aj. Cancer J. 2008 Jan-Feb;14(1):40-5. doi: 10.1097/PPO.0b013e318161d40f. Cancer J. 2008. PMID: 18303482 Review.
383 results